 In summary, this research has shown a decrease in the number of papillary thyroid carcinomas over the past two decades, as well as a decrease in the number of patients with more advanced stages of the disease and those with the worst prognosis. Additionally, there has been a significant drop in mortality rates among patients with follicular thyroid carcinomas, which can be attributed to improvements in treatment protocols. This article was authored by B.B. Gouda, A.E. Kovalenko, M.U. Bogov and others.